Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge.
Parseghian CM, Loree JM, Morris VK, Liu X, Clifton KK, Napolitano S, Henry JT, Pereira AA, Vilar E, Johnson B, Kee B, Raghav K, Dasari A, Wu J, Garg N, Raymond VM, Banks KC, Talasaz AA, Lanman RB, Strickler JH, Hong DS, Corcoran RB, Overman MJ, Kopetz S.
Parseghian CM, et al. Among authors: johnson b.
Ann Oncol. 2019 Feb 1;30(2):243-249. doi: 10.1093/annonc/mdy509.
Ann Oncol. 2019.
PMID: 30462160
Free PMC article.